Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 1,964 Shares of Cigna Group $CI

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its position in shares of Cigna Group (NYSE:CIFree Report) by 3.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,135 shares of the health services provider’s stock after selling 1,964 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Cigna Group were worth $17,101,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Beacon Financial Strategies CORP acquired a new position in shares of Cigna Group during the fourth quarter valued at about $28,000. Collier Financial acquired a new position in shares of Cigna Group during the third quarter valued at about $34,000. Lodestone Wealth Management LLC acquired a new position in shares of Cigna Group during the fourth quarter valued at about $32,000. Creative Financial Designs Inc. ADV raised its holdings in shares of Cigna Group by 147.3% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 81 shares during the period. Finally, Activest Wealth Management raised its holdings in shares of Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 126 shares during the period. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Down 0.1%

CI opened at $277.08 on Monday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The firm has a market capitalization of $73.30 billion, a PE ratio of 11.75, a P/E/G ratio of 1.00 and a beta of 0.28. The company’s 50-day moving average is $278.32 and its 200 day moving average is $277.01.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same quarter in the prior year, the business posted $6.74 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, research analysts predict that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CI shares. Raymond James Financial set a $340.00 price objective on shares of Cigna Group in a report on Friday, May 1st. Truist Financial upped their price objective on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Royal Bank Of Canada upped their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. UBS Group upped their price objective on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Finally, Wells Fargo & Company upped their target price on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.50.

View Our Latest Report on CI

Insider Buying and Selling

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.